Analysts expect over 2021 rising revenue Sanofi-Aventis, quite high dividend

Tomorrow the French Sanofi-Aventis will report its past quarters results. Over the current book year the total revenue will be 37.56 billion euros (consensus estimates). This is slightly more than 2020's revenue of 37.37 billion euros.

Historical revenues and results Sanofi-Aventis plus estimates 2020

The analysts expect for 2021 a net profit of 7.67 billion euros. For this year the consensus of the result per share is a profit of 6.13 euros. Based on this the price/earnings-ratio is 13.93.

Huge dividend Sanofi-Aventis

For this year most of the analysts expect a dividend of 3.28 euros per share. Sanofi-Aventis 's dividend yield thus equals 3.84 percent. The average dividend yield of the pharmaceutical companies is a limited 1.39 percent.

Most recent target prices around 98 euros

The most recent recommendations for the pharmaceutical company are from JP Morgan, Kepler Capital Markets and Credit Suisse .

Sanofi-Aventis 's market capitalization is based on the number of outstanding shares around 107.05 billion euros. The Sanofi-Aventis stock was the past 12 months quite volatile. Since last April the stock is 5 percent lower. This year the stock price moved between 75 and 96 euro.

Historical stock prices Sanofi-Aventis

At 9.34 the stock trades 1 percent higher at 85.38 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.